Please login to the form below

Not currently logged in
Email:
Password:

Global Fund

This page shows the latest Global Fund news and features for those working in and with pharma, biotech and healthcare.

Merck signs separate agreements with Seattle Genetics for two cancer drugs

Merck signs separate agreements with Seattle Genetics for two cancer drugs

In addition to the commercialisation agreement, Merck will also co-fund a portion of the Tukysa global development plan, which includes several ongoing and planned trials across HER2-positive cancers. ... Seattle Genetics will receive $85m in prepaid

Latest news

More from news
Approximately 1 fully matching, plus 31 partially matching documents found.

Latest Intelligence

  • Risks, reforms and rewards: the evolving Russian healthcare market Risks, reforms and rewards: the evolving Russian healthcare market

    The NGO system primarily focuses on advocacy, however it also plays a role in direct care in collaboration with the Government and international organisations including the Global Fund To Fight AIDS,

  • The race for a HIV ‘cure’ The race for a HIV ‘cure’

    nd. International AIDS conference held in the Netherlands in July and attended by 15, 000 global policy makers, researchers and advocates, had a very different mood to its first, when times ... The company’s annual R&D budget is $3.3bn which helps fund

  • The world is our laboratory The world is our laboratory

    This year, through J&J Innovation, we will invest $10m into the UK government-led Global Dementia Discovery Fund, supporting innovative research into the area. ... This is a global, not just European, drive; when I attended this year's Annual Meeting for

  • Pharma deals during January 2013 Pharma deals during January 2013

    cancer. BMS held rights to North America and Japan leaving Lilly sole global rights. . ... Acquisition. Contraception fertility. 305. Syncona / Wellcome Trust .  . New biotech investment fund.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Former PEPFAR head Mark Dybul to lead the Global Fund Former PEPFAR head Mark Dybul to lead the Global Fund

    The Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed renowned AIDS expert Dr Mark Dybul as executive director. ... Mark Dybul is a true leader, who can take the Global Fund to the next level,” said Simon Bland, board chair of the

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics